195 related articles for article (PubMed ID: 22733720)
1. Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.
Kouprina N; Lee NC; Pavlicek A; Samoshkin A; Kim JH; Lee HS; Varma S; Reinhold WC; Otstot J; Solomon G; Davis S; Meltzer PS; Schleutker J; Larionov V
Genes Chromosomes Cancer; 2012 Oct; 51(10):933-48. PubMed ID: 22733720
[TBL] [Abstract][Full Text] [Related]
2. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.
Kouprina N; Pavlicek A; Noskov VN; Solomon G; Otstot J; Isaacs W; Carpten JD; Trent JM; Schleutker J; Barrett JC; Jurka J; Larionov V
Genome Res; 2005 Nov; 15(11):1477-86. PubMed ID: 16251457
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of SPANX genes in families with X-linked prostate cancer.
Kouprina N; Noskov VN; Solomon G; Otstot J; Isaacs W; Xu J; Schleutker J; Larionov V
Prostate; 2007 Jun; 67(8):820-8. PubMed ID: 17373721
[TBL] [Abstract][Full Text] [Related]
4. A 105 kb interstitial insertion in the Xq27.1 palindrome from pseudoautosomal region PAR1 causes a novel X-linked recessive compound phenotype.
Si N; Meng X; Zhao Z; Xia W; Zhang X
J Transl Med; 2019 Apr; 17(1):138. PubMed ID: 31036090
[TBL] [Abstract][Full Text] [Related]
5. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
[TBL] [Abstract][Full Text] [Related]
6. NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.
Mattila H; Schindler M; Isotalo J; Ikonen T; Vihinen M; Oja H; Tammela TL; Wahlfors T; Schleutker J
BMC Cancer; 2011 Aug; 11():327. PubMed ID: 21810217
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.
Bailey-Wilson JE; Childs EJ; Cropp CD; Schaid DJ; Xu J; Camp NJ; Cannon-Albright LA; Farnham JM; George A; Powell I; Carpten JD; Giles GG; Hopper JL; Severi G; English DR; Foulkes WD; Mæhle L; Møller P; Eeles R; Easton D; Guy M; Edwards S; Badzioch MD; Whittemore AS; Oakley-Girvan I; Hsieh CL; Dimitrov L; Stanford JL; Karyadi DM; Deutsch K; McIntosh L; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Thibodeau SN; McDonnell SK; Hebbring S; Lange EM; Cooney KA; Tammela TL; Schleutker J; Maier C; Bochum S; Hoegel J; Grönberg H; Wiklund F; Emanuelsson M; Cancel-Tassin G; Valeri A; Cussenot O; Isaacs WB;
BMC Med Genet; 2012 Jun; 13():46. PubMed ID: 22712434
[TBL] [Abstract][Full Text] [Related]
8. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
[TBL] [Abstract][Full Text] [Related]
9. Xq27-28 deletions in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Genes Chromosomes Cancer; 2003 Aug; 37(4):381-8. PubMed ID: 12800149
[TBL] [Abstract][Full Text] [Related]
10. Genetic linkage analysis of prostate cancer families to Xq27-28.
Peters MA; Jarvik GP; Janer M; Chakrabarti L; Kolb S; Goode EL; Gibbs M; DuBois CC; Schuster EF; Hood L; Ostrander EA; Stanford JL
Hum Hered; 2001; 51(1-2):107-13. PubMed ID: 11096277
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
Xu J
Am J Hum Genet; 2000 Mar; 66(3):945-57. PubMed ID: 10712209
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
Farnham JM; Camp NJ; Swensen J; Tavtigian SV; Albright LA
Hum Genet; 2005 Feb; 116(3):179-85. PubMed ID: 15592687
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
Bochum S; Paiss T; Vogel W; Herkommer K; Hautmann R; Haeussler J
Prostate; 2002 Jun; 52(1):12-9. PubMed ID: 11992616
[TBL] [Abstract][Full Text] [Related]
15. Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.
Johanneson B; McDonnell SK; Karyadi DM; Quignon P; McIntosh L; Riska SM; FitzGerald LM; Johnson G; Deutsch K; Williams G; Tillmans LS; Stanford JL; Schaid DJ; Thibodeau SN; Ostrander EA
Hum Mol Genet; 2010 Oct; 19(19):3852-62. PubMed ID: 20631155
[TBL] [Abstract][Full Text] [Related]
16. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.
Rökman A; Baffoe-Bonnie AB; Gillanders E; Fredriksson H; Autio V; Ikonen T; Gibbs KD; Jones M; Gildea D; Freas-Lutz D; Markey C; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Trent J; Bailey-Wilson JE; Schleutker J
Hum Genet; 2005 Jan; 116(1-2):43-50. PubMed ID: 15549392
[TBL] [Abstract][Full Text] [Related]
17. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
[TBL] [Abstract][Full Text] [Related]
18. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.
Yaspan BL; McReynolds KM; Elmore JB; Breyer JP; Bradley KM; Smith JR
Hum Genet; 2008 May; 123(4):379-86. PubMed ID: 18350320
[TBL] [Abstract][Full Text] [Related]
19. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
[TBL] [Abstract][Full Text] [Related]
20. Expression of SPANX proteins in normal prostatic tissue and in prostate cancer.
Salemi M; Calogero AE; Zaccarello G; Castiglione R; Cosentino A; Campagna C; Vicari E; Rappazzo G
Eur J Histochem; 2010; 54(3):e41. PubMed ID: 20839415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
